Talphera, Inc. (TLPH:NASDAQ) closed at $1.07 on October 15, 2026, up 0.94% on the day. The stock trades 31.8% below its 52-week high of $1.57 and 55.1% above its 52-week low of $0.690. Over the past year, it lost 7.8%. Talphera, Inc. is part of the Health Care sector.
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| -0.93% | -10.08% | -17.05% | +37.18% | -7.76% |
In 252 trading sessions since October 15, 2025, TLPH closed higher on 109 days (43%). Its best day was February 23, 2026 (+20.51%) and its worst was November 13, 2025 (-18.60%). The stock moved 10% or more in a single session 9 times. It opened at least 5% above the previous day's high 1 time.
AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its product portfolio includes DSUVIA and Zalviso for Moderate-to-severe acute pain. The company's products under pipeline are ARX-02 and ARX-03. The majority of its revenue is generated from DSUVIA product sales in the United States.
Find more stocks like TLPH with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.